S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OTLK Outlook Therapeutics Inc

8.54

0.04 (0.47%)

Last Updated: 03:44:58

Delayed by 15 minutes

Bullish Price Target By Chardan Capital Stirs Up Traders

A New Jersey-based biotech company turned the heads of both investors and apparently analysts after it was announced that Chardan Capital started the company at a...

To read the full story on AllPennyStocks.com, click here.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics Inc News

Outlook Therapeutics® to Present at the Retina World Congress 2024
Thursday 2 May 2024 (5 hours ago) • GlobeNewswire Inc.

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Monday 29 April 2024 (3 days ago) • GlobeNewswire Inc.

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
Friday 22 March 2024 (1 month ago) • GlobeNewswire Inc.

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

More Outlook Therapeutics Inc News Articles

Commonwealth Bank Of Aus...

Westpac Banking

JP Morgan Chase

Australian SE All Ordina...

Sterling vs AUD

Australia And New Zealan...

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions